France· FR:60522572
LEUSTATINE 1 mg/ml, solution pour perfusion
A medicinal product containing cladribine, registered in France by ATNAHS PHARMA NETHERLANDS (PAYS-BAS).
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CLADRIBINE
- Manufacturer
- ATNAHS PHARMA NETHERLANDS (PAYS-BAS)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009561242371 flacon(s) en verre de 10 ml
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Cladribine in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaLEUJECTAtnahs Pharma Netherlands B.V., Amsterdam
- United StatesCladribineApotex Corp.
- FinlandLeujectAtnahs Pharma Netherlands B.V.
- SpainLEUSTATIN 1 MG/ML SOLUCION PARA PERFUSIONAtnahs Pharma Netherlands Bv.
- SwitzerlandLitak 10, Injektions- / InfusionslösungLipomed AG
- NetherlandsLeustatin 2 mg/ml oplossing voor injectieAtnahs Pharma Netherlands B.V.
- PolandBiodribinSieć Badawcza Łukasiewicz – Instytut Chemii Przemysłowej im. Prof. I. Mościckiego
- United KingdomLeustat 10mg/10ml solution for infusion vialsAtnahs Pharma UK Ltd
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Austria · Leuject
- Belgium · Leustatin
- Bulgaria · Леуджект
- Czechia · Leuject
- Germany · Leustatin
- Spain · Leustatin
- Finland · Leuject
- United Kingdom (Northern Ireland) · Cladribine Zentiva, Leustat
- Greece · Leustatin
- Croatia · Leuject
- Hungary · Leuject
- Iceland · Mavenclad
- Italy · Leustatin
- Liechtenstein · Mavenclad
- Luxembourg · Leustatin
- Netherlands · Leustatin
- Norway · Leuject, Mavenclad
- Poland · Biodribin, Leuject
- Portugal · Cladribina Generis, Leustatin
- Romania · Leuject
- Sweden · Leuject
- Slovenia · Leuject
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/eb91b38b-7d70-4c71-92ff-d955fdc5faf8 GET /v1/drugs/eb91b38b-7d70-4c71-92ff-d955fdc5faf8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "60522572",
"date_amm": "1994-09-05",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "CLADRIBINE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution pour perfusion",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about cladribine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.